fMRI Feasibility Older Hip Fracture Surgery

May 5, 2022 updated by: University of Nottingham

Functional MRI in Older People Following Hip Fracture Surgery: a Feasibility Study

An assessment of the feasibility of structural and functional magnetic resonance imaging (MRI) brain scans in older people who have recovered from and older people who never had delirium after hip fracture surgery

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

Postoperative delirium, an acute sate of confusion occurs with higher frequency in older people. Hip fracture surgery is a procedure associated with an increased risk of postoperative delirium.

In the study the feasibility of achieving structure and functional connectivity imaging of the brain, using magnetic resonance imaging, in older people who are recovering from hip fracture surgery will be assessed.

People who have recovered from post operative delirium and people who did not have postoperative delirium will be included.

Study Type

Observational

Enrollment (Anticipated)

10

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Older people recovering from hip fracture surgery

Description

Inclusion Criteria:Age

  • Age ≥ 65 years
  • Cognitively intact
  • primary admission for hip fracture surgery

Exclusion Criteria:

  • Cognitive impairment
  • Less than moderate level of activities of daily living
  • History of neurosurgery/significant head trauma
  • Acutely unwell/moribund
  • Presence of neurological diseases including overt stroke, dementia, multiple sclerosis, Parkinson's disease, intracranial tumours and other significant neurologic disorders.
  • Postural or movement disorders likely to impede MRI scan
  • Contraindications to MRI
  • Complex fractures/multiple injuries

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Never had delirium
Older people recovering from hip fracture surgery who did not have postoperative delirium
Series of MRI scans of the brain
Recovered delirium
Older people recovering from hip fracture surgery who experienced delirium which has resolved
Series of MRI scans of the brain

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of MRI in older people following hip fracture surgery assessed by tolerability of transfer to scanner and the scanning process
Time Frame: From time of consent to day after MRI scan which is up to 5 days
The feasibility of transferring participants to and achieving structural and functional MRI scans. Specifically we will assess the number of participants in whom scans were successfully achieved
From time of consent to day after MRI scan which is up to 5 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Abnormalities of functional connectivity
Time Frame: Up to one month after scans have been achieved
Identify any differences in functional connectivity between the resolved delirium and the never delirium MRI scans
Up to one month after scans have been achieved
Pain assessment.
Time Frame: From immediately prior to transfer to the MRI suite until return to own hospital bed which is approximately 2 hours
An assessment of baseline pain levels and then repeat assessments of pain during transfer and the MRI scanning process using the numerical pain rating scale
From immediately prior to transfer to the MRI suite until return to own hospital bed which is approximately 2 hours
Actual times taken to achieve scans
Time Frame: Up to 60 minutes
An assessment of unforeseen constraints on time taken to scan
Up to 60 minutes
Participant feedback
Time Frame: Two occassions. The first immediately after return from the MRI scan suite. The second will occur the day after scanning. Each will take 5 minutes.
The participant experience will be explored via verbal feedback which will be documented by the accompanying researcher
Two occassions. The first immediately after return from the MRI scan suite. The second will occur the day after scanning. Each will take 5 minutes.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rob Dineen, PhD, University of Nottingham

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

July 4, 2022

Primary Completion (Anticipated)

September 2, 2022

Study Completion (Anticipated)

December 6, 2022

Study Registration Dates

First Submitted

February 28, 2020

First Submitted That Met QC Criteria

October 5, 2021

First Posted (Actual)

October 18, 2021

Study Record Updates

Last Update Posted (Actual)

May 6, 2022

Last Update Submitted That Met QC Criteria

May 5, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

Incidental findings in participants who give consent for sharing of these with their physician, will be communicated to the general practitioner for further action if required.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Delirium

Clinical Trials on Functional MRI

Subscribe